Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  cognitive/functional effects of cancer therapy
Trial Type:  Supportive care
Results 1-25 of 27 for your search:
Start Over
Atorvastatin Calcium in Preventing Cardiovascular Complications in Patients with Newly Diagnosed Stage I-III Breast Cancer or Lymphoma Undergoing Anthracycline-Based Chemotherapy
Phase: Phase III, Phase II
Type: Supportive care
Age: 30 to 80
Trial IDs: 98213, NCI-2013-01760, 00024197, CCCWFU 98213, WF 98213, WFU 98213, NCT01988571
Yoga or Stretching and Relaxation in Improving Physical Function in Patients with Stage 0-III Breast Cancer Undergoing Radiation Therapy
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 2009-0976, NCI-2012-01895, NCT01202851
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: ANZGOG-0902/GOG-0274/RTOG-1174, NCI-2011-02978, ANZGOG-0902, CDR0000706698, GOG-0274, RTOG-1174, ANZGOG-0902-GOG-0274, NCT01414608
Armodafinil in Reducing Cancer-Related Fatigue in Patients with High-Grade Glioma
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: A221101, NCI-2012-02020, N10C3, NCT01781468
Carboplatin, Melphalan, Etoposide Phosphate, Mannitol, and Sodium Thiosulfate in Treating Patients With Previously Treated Brain Tumors
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 to 75
Trial IDs: SOL-04058-L, NCI-2013-00786, 2868, OHSU-8507, OHSU-2868, OHSU-SOL-04058-L, NCT00303849
Bevacizumab, Minocycline Hydrochloride, and Radiation Therapy in Treating Patients with Recurrent Glioma
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: IRB# 55264, NCI-2012-01118, HCI55264, NCT01580969
Modafinil in Treating Children with Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
Phase: Phase II
Type: Supportive care
Age: 6 to 19
Trial IDs: ACCL0922, NCI-2011-02594, CDR0000702733, SCUSF 0901, NCT01381718
Rituximab, Methotrexate, Procarbazine Hydrochloride, Vincristine Sulfate, and Cytarabine with or without Radiation Therapy in Treating Patients with Primary Central Nervous System Lymphoma
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 1114, NCI-2011-02678, CDR0000703682, NCT01399372
Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
Phase: Phase II
Type: Supportive care, Treatment
Age: 3 to 21
Trial IDs: ACNS1123, NCI-2012-01967, CDR0000734032, COG-ACNS1123, NCT01602666
Enhanced Physical Activity in Improving Cognitive Late Effects in Younger Patients with Brain Tumors Who Have Undergone Radiation Therapy
Phase: Phase II
Type: Supportive care
Age: 8 to 17
Trial IDs: 14-C-0116, NCI-2014-02501, NCT02153957
Stereotactic Radiosurgery in Treating Patients with Brain Metastases after Surgery
Phase: Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: RADONC1962-11, NCI-2011-03387, IRB00049695, NCT01395407
Supervised Aerobic Training or Progressive Stretching in Improving Quality of Life in Patients with Metastatic Breast Cancer Receiving Anticancer Therapy
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Age: 21 to 80
Trial IDs: 14-170, NCI-2014-00079, NCT02239848, NCT01725633
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 1 to 17
Trial IDs: AALL06N1, NCI-2009-00315, CDR0000528920, COG-AALL06N1, NCT00437060
Changes in Brain Function in Patients with Breast Cancer or Lymphoma Receiving Chemotherapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: Not specified
Trial IDs: URCC10055, NCI-2011-02878, 10055, CDR0000697582, NCT01382082
Biologic and Pathophysiologic Effects of Radiation Therapy in Younger Patients With Central Nervous System Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 21 and under
Trial IDs: 06-C-0219, NCI-2013-02056, 060219, P6810, NCT01445288
Macimorelin in Treating Cachexia in Patients With Solid Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: H-27747, NCI-2012-01772, NCT01614990
Memory and Thinking Skills Workshop in Improving Cognitive Rehabilitation in Gynecologic and Breast Cancer Survivors
Phase: No phase specified
Type: Diagnostic, Supportive care
Age: 21 to 90
Trial IDs: 7750, NCI-2012-01035, NCT01641068
Melatonin in Treating Childhood Cancer Survivors with Neurocognitive Problems or Sleep Disorders
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: MIND, NCI-2012-02053, NCT01700959
Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: MC1193, NCI-2012-01603, NCT01721343
Neurocognitive Function in Patients With Newly Diagnosed Brain Metastases Undergoing Stereotactic Radiosurgery
Phase: No phase specified
Type: Health services research, Supportive care, Treatment
Age: 18 and over
Trial IDs: 12105, NCI-2013-01358, NAGKC 12-02, NCT01821443
COGNUTRIN in Improving Thinking and Memory in Breast Cancer Survivors
Phase: No phase specified
Type: Supportive care
Age: 45 to 75
Trial IDs: 17089, NCI-2014-00434, MCC-17089, NCT01823991
Geriatric Assessment Intervention for Reducing Chemotherapy Toxicity in Older Patients with Advanced Cancer
Phase: No phase specified
Type: Health services research, Supportive care
Age: 70 and over
Trial IDs: URCC13059, NCI-2013-01904, 13059, NCT02066168, NCT02054741
Meditation in Improving Cognitive Function and Quality of Life in Patients with Stage I-III Breast Cancer
Phase: No phase specified
Type: Supportive care
Age: 35 to 60
Trial IDs: 2012-0156, NCI-2015-00469, NCT02162329
Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients with Localized Prostate Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 to 75
Trial IDs: CASE9814, NCI-2014-01313, NCT02179762
Start Over